Pharmaceutical

Fulvestrant by Kashiv BioSciences for Metastatic Breast...

Nov 6, 2023

Fulvestrant is under clinical development by Kashiv BioSciences and currently in...

TLM-101 by Therillume for Neurofibromatoses Type I (Von...

Nov 6, 2023

TLM-101 is under clinical development by Therillume and currently in Phase I for...

TLM-006 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-006 is under clinical development by Therillume and currently in Phase I for...

AWT-020 by Anwita Biosciences for Lymphoma: Likelihood ...

Nov 6, 2023

AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...

StromaForte by Swedish StromaBio for Ageing: Likelihood...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

StromaForte by Swedish StromaBio for Osteoarthritis: Li...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

STAT turns 8: A letter from the executive editor

STAT turns 8: A letter from the executive editor

Nov 5, 2023

Today STAT turns 8! Read a letter from our executive editor @rickberke on the mi...

STAT+: Senate bill would permanently extend Covid-era rules on telehealth addiction treatment

STAT+: Senate bill would permanently extend Covid-era r...

Nov 5, 2023

A bipartisan bill would permanently extend a Covid-era policy that allowed patie...

STAT+: Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis

STAT+: Novo Nordisk is concluding research on Wegovy’s ...

Nov 5, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

D3L-001 by D3 Bio for Human Epidermal Growth Factor Rec...

Nov 4, 2023

D3L-001 is under clinical development by D3 Bio and currently in Phase I for Hum...

D3L-001 by D3 Bio for Gastroesophageal (GE) Junction Ca...

Nov 4, 2023

D3L-001 is under clinical development by D3 Bio and currently in Phase I for Gas...

RPA-601 by Rocket Pharmaceuticals for Cardiomyopathy: L...

Nov 4, 2023

RPA-601 is under clinical development by Rocket Pharmaceuticals and currently in...

Debio-4127 by Debiopharm International for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET): Likelihood of Approval

Debio-4127 by Debiopharm International for Neuroendocri...

Nov 4, 2023

Debio-4127 is under clinical development by Debiopharm International and current...

HUC-3443 by Huons for Idiopathic (Essential) Hypertensi...

Nov 4, 2023

HUC-3443 is under clinical development by Huons and currently in Phase II for Id...

HUC-3443 by Huons for Hypercholesterolemia: Likelihood ...

Nov 4, 2023

HUC-3443 is under clinical development by Huons and currently in Phase II for Hy...

QL-325 by QLSF Biotherapeutics for Acute Myelocytic Leu...

Nov 4, 2023

QL-325 is under clinical development by QLSF Biotherapeutics and currently in Ph...